CHA Medical Center’s Kwang Yul Cha presents a new approach to reproductive aging... World fertility experts gather in Busan

[Financial News]  Why do repeated IVF procedures fail to result in pregnancy?
Could immunotherapy offer a new option for patients experiencing recurrent miscarriages and implantation failure? Leading reproductive medicine experts from around the world are gathering in Busan to address longstanding challenges in infertility treatment.
According to medical industry sources on the 2nd, the International Society for Immunology of Reproduction (ISIR) will hold the 16th ISIR World Congress at Busan Exhibition and Convention Center (BEXCO) from the 5th to the 8th. The event is designed not only to share the latest research findings, but also to give infertility patients and their families an opportunity to ask world-renowned experts directly about treatment options.
A free public forum taking place over three days starting on the 6th is drawing particular interest. Experts and patients will engage in dialogue focused on problems patients actually face, including repeated IVF failures, miscarriage and implantation disorders.
Participants in the forum include ISIR President Young-hee Kwak; Dr. George Ndukwu of a fertility clinic on Harley Street in the United Kingdom; and Dr. Ricardo Barini of the University of Campinas in Brazil. They will explain the potential applications of immunotherapy and approaches to diagnosing and treating recurrent implantation failure, drawing on actual patient cases.
Kwang Yul Cha, head of the Global Comprehensive Research Institute at CHA Medical Center and CHA Bio Group, will deliver a keynote address on “Managing Reproductive Aging Using K Cells.” Drawing on research experience accumulated in reproductive medicine, including the development of rapid egg-freezing technology and the establishment of an egg bank, he is expected to present new possibilities for cell therapy.
President Kwak will also speak on inflammatory changes in the ovaries and abnormalities in immune regulation. International scholars, including Gil Mor of Wayne State University in the United States, will share research findings on immune responses during pregnancy and women’s health.
Reproductive immunology is the field that studies the role of the immune system during pregnancy and childbirth. It has attracted interest for its work to identify the causes of recurrent miscarriage and implantation failure and explore new treatment possibilities. However, the actual use of immunotherapy should be determined by considering each patient’s diagnosis and the available medical evidence.
The congress is also significant because it extends researcher-focused discussion to the practical treatment concerns of patients. It focuses in particular on accurately diagnosing the causes of repeated treatment failures and exploring treatment approaches tailored to individual patients.
A medical industry source said, “Infertility treatment is moving away from simply increasing the number of procedures and toward carefully analyzing the causes of repeated failures,” and noted, “The key question going forward is whether reproductive immunology research can lead to treatment strategies tailored to individual patients.”
President Kwak said, “We designed this so that research findings in reproductive immunology would not remain within academic discussions, but could reach infertility patients more directly,” adding, “I hope it will help patients understand their own treatment process.”
The International Society for Immunology of Reproduction is an international academic organization founded in 1975 and was co-founded by Professor Robert Edwards, a key figure in the birth of the world’s first test-tube baby and a Nobel Prize laureate in Physiology or Medicine. Anyone can attend the public forum free of charge by registering in advance.
[email protected] Kim Gyeong-a Reporter